The lock-in period for shares of Mathillo Mailung Khola Jalvidyut Company, Chirkhwa Hydropower Company and Sopan Pharmaceuticals is set to end within the next month, allowing the affected shares to become eligible for trading after their respective restrictions expire. Among them, the lock-in period for 214,500 mutual fund shares allotted in Sopan Pharmaceuticals is scheduled to end on Kartik 16.
Sopan Pharmaceuticals shares become eligible after Kartik 16
The 214,500 Sopan Pharmaceuticals shares covered by the upcoming expiry were allotted to mutual funds. Once the lock-in period ends on Kartik 16, those shares become eligible for trading. The expiry removes the restriction on trading the shares; it does not, by itself, mean that they will be sold.
The shares associated with the lock-in expiries across the three companies are held by founders, affected locals and mutual funds. The Sopan Pharmaceuticals allocation identified in the available details is specifically the mutual fund portion. The information provided does not give a separate share count or expiry date for the holdings in Mathillo Mailung Khola Jalvidyut Company or Chirkhwa Hydropower Company.
Three companies included in the upcoming expiries
The companies named in the coming month’s lock-in schedule represent hydropower and pharmaceutical businesses: Mathillo Mailung Khola Jalvidyut Company and Chirkhwa Hydropower Company, alongside Sopan Pharmaceuticals. Their shares will become eligible for trading as their individual lock-in periods end.
A lock-in period restricts the trading of specified shares for a defined time. The expiry therefore changes whether the shares can be traded, while any decision by the holders to sell remains separate. Founders, affected locals and mutual funds are among the holder groups identified for the shares covered by these expiries.
The Sopan Pharmaceuticals date provides a specific point in the schedule: Kartik 16. For the other two companies, the available details confirm that their lock-in periods are ending within the next month, but do not state their exact dates or the quantities of shares involved. Accordingly, the confirmed figure in the information available is the 214,500 mutual fund shares allotted in Sopan Pharmaceuticals.
The upcoming expiries mark the end of trading restrictions for shares held across all three companies. Investors will be able to trade eligible shares once the relevant lock-in periods have concluded, including the identified Sopan Pharmaceuticals mutual fund shares after Kartik 16.
